Acadia Healthcare Company, Inc. (NASDAQ:ACHC) updated its FY17 earnings guidance on Thursday. The company provided EPS guidance of $2.42-2.47 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.45. The company issued revenue guidance of $2.85-2.87 billion, compared to the consensus revenue estimate of $2.87 billion.

A number of brokerages have weighed in on ACHC. BidaskClub upgraded Acadia Healthcare from a sell rating to a hold rating in a research note on Saturday, June 10th. KeyCorp reaffirmed an overweight rating and set a $51.00 target price on shares of Acadia Healthcare in a report on Thursday, June 1st. Jefferies Group LLC reaffirmed a buy rating on shares of Acadia Healthcare in a report on Friday, May 5th. Zacks Investment Research downgraded Acadia Healthcare from a hold rating to a sell rating in a report on Thursday, April 6th. Finally, Cantor Fitzgerald reaffirmed a hold rating and set a $45.00 target price on shares of Acadia Healthcare in a report on Wednesday, April 26th. Three research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company. The company presently has a consensus rating of Buy and a consensus target price of $57.23.

Shares of Acadia Healthcare Company, Inc. (ACHC) traded down 0.06% during mid-day trading on Thursday, hitting $49.23. The company had a trading volume of 1,283,904 shares. Acadia Healthcare Company, Inc. has a 12-month low of $32.54 and a 12-month high of $57.29. The firm has a market cap of $4.32 billion, a PE ratio of 286.22 and a beta of 1.14. The firm’s 50 day moving average is $48.22 and its 200-day moving average is $43.60.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.89% and a net margin of 0.53%. The company had revenue of $715.90 million for the quarter, compared to analyst estimates of $717.38 million. During the same period in the prior year, the company posted $0.73 EPS. The company’s revenue was down 5.4% compared to the same quarter last year. On average, equities analysts expect that Acadia Healthcare Company, Inc. will post $2.44 EPS for the current year.

In other news, Director William Grieco sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, June 16th. The stock was sold at an average price of $45.42, for a total value of $90,840.00. Following the sale, the director now directly owns 47,013 shares in the company, valued at approximately $2,135,330.46. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Reeve B. Waud sold 724,694 shares of the company’s stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $45.53, for a total value of $32,995,317.82. The disclosure for this sale can be found here. Over the last quarter, insiders sold 968,102 shares of company stock worth $44,283,109. Corporate insiders own 11.10% of the company’s stock.

TRADEMARK VIOLATION WARNING: This article was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with's FREE daily email newsletter.